(Total Views: 475)
Posted On: 05/27/2021 3:11:44 AM
Post# of 151807
Vaccine-long-haulers now?
As if stonewalling therapeutics wasn't bad enough.
Bruce K. Patterson MD,
@brucep13
"Breaking data: post-vaccination COVID negative patients with symptoms months out from vaccine have elevated pro-inflammatory markers CCL5/RANTES and TNF-a!!"
some interesting comments, scroll down
https://twitter.com/brucep13/status/1397687269486518272
So, now we have "Vaccine Long Haulers". Is this why Bruce wants to be CEO or something?
Is there an expert here in the building? Please pick up the phone.
***************************
"One potential hurdle for antibody-based vaccines and therapeutics is the risk of exacerbating COVID-19 severity via antibody-dependent enhancement (ADE). ADE can increase the severity of multiple viral infections, including other respiratory viruses such as respiratory syncytial virus (RSV)9,10 and measles11,12
https://www.nature.com/articles/s41564-020-00789-5
https://www.chop.edu/centers-programs/vaccine...d-vaccines
As if stonewalling therapeutics wasn't bad enough.
Bruce K. Patterson MD,
@brucep13
"Breaking data: post-vaccination COVID negative patients with symptoms months out from vaccine have elevated pro-inflammatory markers CCL5/RANTES and TNF-a!!"
some interesting comments, scroll down
https://twitter.com/brucep13/status/1397687269486518272
So, now we have "Vaccine Long Haulers". Is this why Bruce wants to be CEO or something?
Is there an expert here in the building? Please pick up the phone.
***************************
"One potential hurdle for antibody-based vaccines and therapeutics is the risk of exacerbating COVID-19 severity via antibody-dependent enhancement (ADE). ADE can increase the severity of multiple viral infections, including other respiratory viruses such as respiratory syncytial virus (RSV)9,10 and measles11,12
https://www.nature.com/articles/s41564-020-00789-5
https://www.chop.edu/centers-programs/vaccine...d-vaccines
(2)
(0)Scroll down for more posts ▼
